Komori
KYORIN Pharmaceutical (4569) · InitiativeFirst stated

Termination of the Distribution Agreement for the KYORIN Infectious Disease Protection Kit

First written in FY2021-Q2. . Latest entry: FY2021-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Business Impact from Termination or Unfavorable Amendment of Important ContractsA theme 94 companies write about · 100 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2018: 7 of 40 companies on the "Worse" side.

11 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 94 companies compared. The sentences above are computed from all 94.
Full recordFilings, disclosures and news, newest first
  1. FY2021-Q2First statedAnnual report

    「Domestic distribution agreement (in-licensing); contracting company: KYORIN Pharmaceutical Co.,Ltd. (consolidated subsidiary); product: KYORIN infectious disease protection kit; counterparty: Azeus Corporation; contract year: 2013.」

    The distribution agreement with Azeus Corporation for the KYORIN infectious disease protection kit was terminated during the second quarter of the consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Termination of the Distribution Agreement for the KYORIN Infectious Disease Protection Kit | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori